Global Immunoassay Markets to 2025 – Growing Adoption of Immunoassay-based POC Diagnostics

NEXT STORY
India In Vitro Diagnostics (IVD) Market Outlook, 2025: Fully Automated Systems are Being Adopted, Increasing Number of Phase-III Clinical Trials
PREV STORY
Royal Biologics Announces the Launch of Cryo-Cord™, the First Non-DMSO Viable Umbilical Cord Graft
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Orion and Bayer jointly present new data in prostate cancer from the Darolutamide ARAMIS -study

Orion Corporation                                                        Press Release 5 February 2019 at 3.00 p.m. EET Orion and Bayer ...

author_avatar
NASDAQ Market News

Cybrexa Therapeutics Appoints Keely Zipp as Vice President of Marketing 

Adds oncology marketing and strategy experience from Incyte Corporation and GlaxoSmithKlineNEW HAVEN, Conn., Oct. ...

author_avatar
NASDAQ Market News

Cue Biopharma Announces Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

CAMBRIDGE, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma™, Inc., (NASDAQ: CUE) an ...

author_avatar
NASDAQ Market News